JP Morgan Chase
CBST

JP Morgan Chase’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

JP Morgan Chase’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-646,260
Closed -$65M – 4481
2014
Q4 		$65M Buy
646,260
+507,315
+365% +$39.4M 0.01% 805
2014
Q3 		$9.22M Sell
138,945
-6,731
-5% -$442K ﹤0.01% 1975
2014
Q2 		$10.2M Buy
145,676
+11,081
+8% +$754K ﹤0.01% 1741
2014
Q1 		$9.85M Buy
134,595
+6,763
+5% +$504K ﹤0.01% 1733
2013
Q4 		$8.8M Sell
127,832
-622,678
-83% -$40.3M ﹤0.01% 1839
2013
Q3 		$47.7M Buy
750,510
+151,522
+25% +$9.16M 0.01% 811
2013
Q2 		$28.9M Buy
+598,988
New +$29.4M 0.01% 1029

JP Morgan Chase's CBST Position: Q1 2015 in Review

JP Morgan Chase sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 646,260 shares — an estimated $65M sold.

JP Morgan Chase first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $65M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • JP Morgan Chase reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • JP Morgan Chase sold 646,260 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $65M.
  • JP Morgan Chase first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • JP Morgan Chase's CUBIST PHARMACEUTICALS INC position peaked at $65M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.